Archive · 21 Aug 2025
WHO Urges Prioritizing Pregnant Women in TB Research
The World Health Organization (WHO) wants to make sure that pregnant and breastfeeding women are included in research about tuberculosis (TB), which is a very contagious disease.
Every year, many women get TB during or after pregnancy, but they are often left out of studies for new medicines and vaccines.
This means doctors don't have all the information they need to help these women and their babies.
The WHO says that these women should be part of the research so that they can get the best care.
They have released a plan with steps to make sure that everyone has a chance to benefit from TB research, which includes more studies, better reporting, and finding ways to help them join these studies.
WHO urges prioritizing pregnant and nursing women in TB research.
An estimated 200,000 pregnant or postpartum women develop TB annually.
Exclusion from trials delays access to life-saving treatments and vaccines.
WHO released a Consensus Statement for equitable TB innovation access.
Statement outlines actions for research, trials, and addressing barriers.
- Who
- World Health Organization (WHO).
- What
- WHO is urging prioritization of pregnant and lactating women in TB research and vaccine trials.
- When
- Annually, an estimated 200,000 pregnant or postpartum women develop TB.
- Where
- Global health community.
- Why
- To ensure equitable access to life-saving TB treatments and vaccines for pregnant and lactating women.
- Organization
- World Health Organization (WHO)
- Focus
- TB research and vaccine trials
- Affected Group
- Pregnant and lactating women
- Estimated Cases
- 200,000 annually
- Document Released
- Consensus Statement